The history of Viagra presents a intricate picture for those considering investment. While the initial introduction generated significant profits, the end of its intellectual property protection opened the avenue to generic competitors, dramatically diminishing revenue. This presents a specific challenge for drug manufacturers banking on related bl

The legacy of Viagra, and its developer copyright, presents a challenging case study for investors. Initially a blockbuster drug, generating billions in income, its exclusivity period created a deluge of generic competition , significantly impacting its market share . While specific firms may try to capitalize on male sexual dysfunction, the presen